Free Trial
CVE:MVN

Madalena Energy (MVN) Stock Price, News & Analysis

Madalena Energy logo
C$0.08 -0.01 (-5.88%)
As of 10/29/2019

About Madalena Energy Stock (CVE:MVN)

Key Stats

Today's Range
C$0.08
C$0.08
50-Day Range
C$0.08
C$0.08
52-Week Range
C$0.08
C$0.21
Volume
111,000 shs
Average Volume
114,547 shs
Market Capitalization
C$43.52 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive MVN Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Madalena Energy and its competitors with MarketBeat's FREE daily newsletter.

MVN Stock News Headlines

Maven build automation tool review
Which Gold Miner Trades at 30% of NAV? The One Buffett Wants
Some of the world’s best gold developers are trading at just 30% of NAV — like buying a dollar for 30 cents. With gold at record highs and Bridgewater now buying in, one analyst believes Buffett’s next move could hit by August 15th. He’s identified the gold miner that fits Buffett’s profile — plus four smaller plays with even more upside.
Centaurus Energy Inc (CTARF)
Petronas Gas Bhd (PGAS)
See More Headlines

MVN Stock Analysis - Frequently Asked Questions

Madalena Energy's stock was trading at C$0.08 at the start of the year. Since then, MVN shares have increased by 0.0% and is now trading at C$0.08.

Shares of MVN stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.

Based on aggregate information from My MarketBeat watchlists, some other companies that Madalena Energy investors own include Fate Therapeutics (FATE), Pluristem Therapeutics (PSTI), YPF Sociedad Anonima (YPF), Lexicon Pharmaceuticals (LXRX), Bellicum Pharmaceuticals (BLCM), Akebia Therapeutics (AKBA) and Array Technologies (ARRY).

Industry, Sector and Symbol

Stock Exchange
CVE
Sector
Energy
Industry
Oil & Gas E & P
Sub-Industry
N/A
Current Symbol
CVE:MVN
CIK
N/A
Fax
N/A
Employees
93
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
N/A
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
N/A

Debt

Debt-to-Equity Ratio
17.24
Current Ratio
0.84
Quick Ratio
0.53

Sales & Book Value

Annual Sales
C$28.29 million
Price / Sales
1.54
Cash Flow
C$0.00 per share
Price / Cash Flow
30.00
Book Value
C$0.06 per share
Price / Book
1.33

Miscellaneous

Outstanding Shares
544,060,000
Free Float
N/A
Market Cap
C$43.52 million
Optionable
Not Optionable
Beta
N/A
These 7 Stocks Will Be Magnificent in 2025 Cover

Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2025. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.

Get This Free Report

This page (CVE:MVN) was last updated on 7/10/2025 by MarketBeat.com Staff
From Our Partners